| JYHB2400523 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| CYHS2101524 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(4) | Generic Drug | 2021-08-05 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
| JYHB1400826 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2014-06-27 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Company | Certificate Issued | 2015-01-27 | view |
| JYHB1901278 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2019-11-06 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2020-02-18 | view |
| JYHZ2500026 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| CYHS2301251 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(4) | Generic Drug | 2023-05-09 | | Qilu Pharmaceutical (Hainan) Co Ltd | | | view |
| JYHB1501087 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2015-08-12 | | Bristol-Myers Squibb Pharma Eeig;Bristol-Myers Squibb Company | Certificate Issued | 2016-06-01 | view |
| JYHZ2000106 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2020-05-15 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2020-10-13 | view |
| JYHB2400349 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2002752 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2021-01-01 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Filed | 2021-01-22 | view |
| CYHS2403436 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(4) | Generic Drug | 2024-10-13 | | Beijing SL Pharmaceutical Co Ltd | | | view |
| CYHB2300058 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-01-09 | | Shandong New Time Pharmaceutical Co Ltd | | | view |
| JYHB2000240 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2020-03-21 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2020-04-23 | view |
| CYHB2400893 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(原6) | Supplementary Application | 2024-06-26 | | Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd | | | view |
| JYHB2001255 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2020-08-05 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Filed | 2020-08-17 | view |
| JYHZ2500025 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2025-02-07 | | Bristol-Myers Squibb Pharma Eeig;BRISTOL-MYERS Squibb (CHINA) Co Ltd;Patheon Inc | | | view |
| CYHS2301248 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs(4) | Generic Drug | 2023-05-09 | | Qilu Pharmaceutical (Hainan) Co Ltd | | | view |
| JYHZ2000107 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | License Renew | 2020-05-15 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Certificate Issued | 2020-10-13 | view |
| JYHB2400350 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2024-07-09 | | Bristol-Myers Squibb Pharma Eeig;Patheon Inc | | | view |
| JYHB2002751 | 达沙替尼片 | dasatinib | Tablet | Chemical Drugs | Supplementary Application | 2021-01-01 | | Bristol-Myers Squibb Pharma Eeig;Astrazeneca Pharmaceuticals Lp | Filed | 2021-01-22 | view |
